Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, has announced the est...
Australia-based IonOpticks, developer of chromatography columns for mass spectrometry research, has announced the l...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Adalvo Limited in the Europe...
Eli Lilly and Company has announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing aut...
Ireland-headquartered Medtronic plc, a global leader in healthcare technology, has announced its intent to separate its ...
Australia-based Kailo Medical, a global leader in structured reporting for medical imaging, has announced its acquisitio...
Pfizer Inc. has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc., a leading Chinese biop...
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge artificial intelligence (AI)-driven protein engi...
In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Labora...
China-based Viva Biotech recently held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the adv...
Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered in...
US-based Sarepta Therapeutics, Inc. has announced that the Japanese Ministry of Health, Labour, and Welfare (MHLW) has a...
Minghui Pharmaceutical, a late-stage clinical biopharmaceutical company, has announced an exclusive licensing and collab...
UK-based Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life...
Japan-based Shionogi & Co. has entered into an agreement with US-based Apnimed, Inc. for the introduction of sulthia...
At the annual event of Indonesian Women Imaging Society held recently, Siemens Healthineers has unveiled the MAMMOMAT B....
Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, as the Leader of its Healthcare Sector s...
Merck, known as MSD outside of the United States and Canada, has announced the start of construction for a $1 billion, 4...
